173 related articles for article (PubMed ID: 17408460)
1. Stage I/II follicular lymphoma: spread of bcl-2/IgH+ cells in blood and bone marrow from primary site of disease and possibility of clearance after involved field radiotherapy.
Pulsoni A; Starza ID; Frattarelli N; Ghia E; Carlotti E; Cavalieri E; Matturro A; Tempera S; Rambaldi A; Foà R
Br J Haematol; 2007 May; 137(3):216-20. PubMed ID: 17408460
[TBL] [Abstract][Full Text] [Related]
2. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
[TBL] [Abstract][Full Text] [Related]
3. Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: a preliminary report.
Ha CS; Cabanillas F; Lee MS; Besa PC; McLaughlin P; Cox JD
Clin Cancer Res; 1997 Feb; 3(2):215-9. PubMed ID: 9815675
[TBL] [Abstract][Full Text] [Related]
4. Detection of t(14;18) by PCR of IgH/BCL2 fusion gene in follicular lymphoma from archived cytological smears.
Stoos-Veić T; Livun A; Ajduković R; Pejsa V; Jaksić O; Kusec R
Coll Antropol; 2010 Jun; 34(2):425-9. PubMed ID: 20698113
[TBL] [Abstract][Full Text] [Related]
5. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy.
Martin S; Fischer C; Free M; Kurreck B; Stockinger H; Fenk R; Arnold C; Kliszewski S; Meckenstock G; Haas R; Kronenwett R
Eur J Haematol; 2005 Apr; 74(4):282-92. PubMed ID: 15777339
[TBL] [Abstract][Full Text] [Related]
6. Commercial LightCycler-based quantitative real-time PCR compared to nested PCR for monitoring of Bcl-2/IgH rearrangement in patients with follicular lymphoma.
Kornacker M; Kornacker B; Schmitt C; Leo E; Ho AD; Hensel M
Ann Hematol; 2009 Jan; 88(1):43-50. PubMed ID: 18636259
[TBL] [Abstract][Full Text] [Related]
7. Occult lymphoma cells prevalent in autologous marrow from non-Hodgkin's diffuse lymphoma.
Yokoyama J; Fujimiya Y; Yamaguchi T; Shiga K; Saijo Y; Groveman DS; McBain JA; Suzuki Y; Ebina T
Am J Hematol; 2003 May; 73(1):1-11. PubMed ID: 12701113
[TBL] [Abstract][Full Text] [Related]
8. Quantitative PCR detection of t(14;18) bcl-2/JH fusion sequences in follicular lymphoma patients: comparison of peripheral blood and bone marrow aspirate samples.
Bowman A; Jones D; Medeiros LJ; Luthra R
J Mol Diagn; 2004 Nov; 6(4):396-400. PubMed ID: 15507680
[TBL] [Abstract][Full Text] [Related]
9. A real-time (PCR) for a real life…? Quantitative evaluation of BCL2/IGH in follicular lymphoma and its implications for clinical practice.
Janikova A; Mareckova A; Dvorakova D; Bortlicek Z; Tichy B; Navratil M; Kral Z; Pospisilova S; Mayer J
Exp Hematol; 2012 Jul; 40(7):528-539.e4. PubMed ID: 22381682
[TBL] [Abstract][Full Text] [Related]
10. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
[TBL] [Abstract][Full Text] [Related]
11. [Achieving Bcl-2/IgH negativity in peripheral blood/bone marrow after therapy implies better prognosis for patients with follicular lymphoma].
Belada D; Smolej L; Stepánková P; Beránek M; Dvoráková D; Bukac J; Malý J
Vnitr Lek; 2007 Oct; 53(10):1057-63. PubMed ID: 18072430
[TBL] [Abstract][Full Text] [Related]
12. A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma.
Ha CS; Cabanillas F; Lee MS; Tucker SL; McLaughlin P; Rodriguez MA; Younes A; Romaguera JE; Mesina OM; Cox JD
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):188-93. PubMed ID: 16111588
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis between RQ-PCR and digital droplet PCR of BCL2/IGH gene rearrangement in the peripheral blood and bone marrow of early stage follicular lymphoma.
Cavalli M; De Novi LA; Della Starza I; Cappelli LV; Nunes V; Pulsoni A; Del Giudice I; Guarini A; Foà R
Br J Haematol; 2017 May; 177(4):588-596. PubMed ID: 28419517
[TBL] [Abstract][Full Text] [Related]
14. The bcl-2/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity.
Schmitt C; Balogh B; Grundt A; Buchholtz C; Leo A; Benner A; Hensel M; Ho AD; Leo E
Leuk Res; 2006 Jun; 30(6):745-50. PubMed ID: 16297448
[TBL] [Abstract][Full Text] [Related]
15. Correlation between molecular and histopathological diagnoses of B cell lymphomas in bone marrow biopsy and aspirates.
Ilgenfritz RB; Kayasut K; Le Tourneau A; Calendini OA; Ouafi L; Marzac C; Diebold J; Devez F; Ducruit V; Bouchet PE; Audouin J; Molina TJ
J Clin Pathol; 2009 Apr; 62(4):357-60. PubMed ID: 19329714
[TBL] [Abstract][Full Text] [Related]
16. Occult bone marrow involvement in patients with diffuse large B-cell lymphoma: results of a pilot study.
Talaulikar D; Dahlstrom JE; Shadbolt B; McNiven M; Broomfield A; Pidcock M
Pathology; 2007 Dec; 39(6):580-5. PubMed ID: 18027262
[TBL] [Abstract][Full Text] [Related]
17. Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populations.
Ladetto M; Mantoan B; De Marco F; Drandi D; Aguzzi C; Astolfi M; Vallet S; Ricca I; Dell' Aquila M; Pagliano G; Monitillo L; Pollio B; Santo L; Cristiano C; Rocci A; Francese R; Bodoni CL; Borchiellini A; Schinco P; Boccadoro M; Tarella C
Exp Hematol; 2006 Dec; 34(12):1680-6. PubMed ID: 17157165
[TBL] [Abstract][Full Text] [Related]
18. [Bcl-2/JH gene re-arrangement determined by PCR as a means to detect minimal residual disease in malignant lymphomas].
Xiang Z; Chen Y; Li C
Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):290-2. PubMed ID: 10920987
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas.
Palacio C; Acebedo G; Navarrete M; Ruiz-Marcellán C; Sanchez C; Blanco A; López A
Haematologica; 2001 Sep; 86(9):934-40. PubMed ID: 11532621
[TBL] [Abstract][Full Text] [Related]
20. Detection of subclinical systemic disease in primary CNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy-chain genes.
Jahnke K; Hummel M; Korfel A; Burmeister T; Kiewe P; Klasen HA; Müller HH; Stein H; Thiel E
J Clin Oncol; 2006 Oct; 24(29):4754-7. PubMed ID: 16966685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]